The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance por Murithi, JM, Pascal, C, Bath, J, Boulenc, X, Gnädig, NF, Pasaje, CFA, Rubiano, K, Yeo, T, Mok, S, Klieber, S, Desert, P, Jiménez-Díaz, MB, Marfurt, J, Rouillier, M, Cherkaoui-Rbati, MH, Gobeau, N, Wittlin, S, Uhlemann, A-C, Price, R, Wirjanata, G, Noviyanti, R, Tumwebaze, P, Cooper, RA, Rosenthal, PJ, Sanz, LM, Gamo, FJ, Joseph, J, Singh, S, Bashyam, S, Augereau, JM, Giraud, E, Bozec, T, Vermat, T, Tuffal, G, Guillon, J-M, Menegotto, J, Sallé, L, Louit, G, Cabanis, M-J, Nicolas, MF, Doubovetzky, M, Merino, R, Bessila, N, Angulo-Barturen, I, Baud, D, Bebrevska, L, Escudié, F, Niles, JC, Blasco, B, Campbell, S